Vir Biotech partners with WuXi on COVID-19 antibody treatment
27-02-2020
motortion films / Shutterstock.com
Antibody patenting can be a minefield for IP practitioners if they lack the most up-to-date knowledge about the best way to approach a patent application. Antibody experts and European patent attorneys Tom Leonard, Alison Care and Dave Wortley from law firm Kilburn & Strode joined WIPR group editor Tom Phillips for a webinar on the latest developments in antibody patenting yesterday, August 5.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
antibodies, patents, Europe, patent applications, EPO, prosecution, drugs, claims, filing, antibody
